H. Shimano et al., INHIBITION OF DIET-INDUCED ATHEROMA FORMATION IN TRANSGENIC MICE EXPRESSING APOLIPOPROTEIN-E IN THE ARTERIAL-WALL, The Journal of clinical investigation, 95(2), 1995, pp. 469-476
Apolipoprotein E (apoE) plays a crucial role in lipoprotein metabolism
both in plasma and in peripheral tissues. To test whether apoE in the
vascular wall has a direct and local effect on atherogenesis, we esta
blished transgenic mice expressing human apoE under control of H2 Ld p
romoter. Studies on mRNA levels and immunohistochemistry demonstrated
that this line was characterized by high expression of human apoE in t
he arterial wall while its expression was relatively low in other tiss
ues as compared with the respective endogenous expression of mouse apo
E. They showed no difference in plasma cholesterol levels and lipoprot
ein profile from controls when fed both normal and atherogenic diets.
However, after 24 wk of an atherogenic diet, the formation of fatty st
reak lesions in proximal aorta was markedly inhibited in transgenic mi
ce as compared with controls. Both lesion area and esterified choleste
rol content were < 30% of those in controls. In a tissue cholesterol l
abeling study with H-3-cholesterol, the specific activity of aorta cho
lesterol was much less in transgenic mice, suggesting that apoE enhanc
es cholesterol efflux from the aortic wall into plasma. Thus, apoE has
anti-atherogenic action which is mediated via enhancing reverse chole
sterol transport from arterial wall.